Literature DB >> 3566023

Organic impotence associated with carbonic anhydrase inhibitor therapy for glaucoma.

R J Epstein, R C Allen, M W Lunde.   

Abstract

Sexual impotence developed in four patients who were receiving carbonic anhydrase inhibitor therapy for glaucoma. Whereas decreased libido has been reported as a side effect of carbonic anhydrase inhibitor therapy, organic impotence has not been documented as an isolated finding.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3566023

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN： 0003-4886


  4 in total

1.  Reversible Anorgasmia with Acetazolamide Treatment for Idiopathic Intracranial Hypertension.

Authors:  Ali Ulvi Uca; Hasan Hüseyin Kozak
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

Review 2.  Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  S S Patel; C M Spencer
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 3.  Erectile dysfunction: symptom or disease?

Authors:  C Foresta; N Caretta; A Aversa; C Bettocchi; G Corona; S Mariani; M Rossato
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

Review 4.  Impotence in elderly men.

Authors:  J E Morley; F E Kaiser
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.